Day: June 21, 2021

NEW YORK, June 21, 2021 (GLOBE NEWSWIRE) — PennantPark Floating Rate Capital Ltd. (NASDAQ: PFLT) (“we,” “our,” “PFLT” or the “Company”) announced today that it has appointed Richard Cheung as its Chief Financial Officer and Treasurer, effective June 21, 2021. Mr. Cheung most recently served as Senior Managing Director and Head of Alternative Investment Accounting at Guggenheim Partners, LLC (“Guggenheim”), where he has served in various roles since 2008. Prior to joining Guggenheim in 2008, Mr. Cheung spent the majority of his career at Ernst & Young LLP in its financial services industry practice where he managed audits for a variety of funds. Mr. Cheung holds a B.S. in Accounting and Finance from the New York University Leonard N. Stern School of Business. “We are extremely pleased that Richard will be joining the Company...

TORONTO, June 21, 2021 (GLOBE NEWSWIRE) — Euro Sun Mining Inc., (TSX: ESM) (“Euro Sun” or the “Company”) reports, in accordance with the policies of the Toronto Stock Exchange, that all matters submitted to shareholders for approval as set out in detail in the Management Information Circular dated May 13, 2021 for the 2021 Annual and Special Meeting of shareholders of the Company (the “Meeting”) were approved by the requisite majority of votes cast at the Meeting. A total of 50,870,977 common shares of the Company were represented by shareholders in person or by proxy at the Meeting, representing 29.71% of the Company’s issued and outstanding common shares. Specifically, shareholders voted to approve:Election of the Board of Directors; Re-appointment of McGovern Hurley LLP as the Company’s external auditors for 2021; and The...

PRINCETON JUNCTION, N.J., June 21, 2021 (GLOBE NEWSWIRE) — MISTRAS Group, Inc. (MG: NYSE) – a leading “one source” multinational provider of integrated technology-enabled asset protection solutions – announced today that Dennis Bertolotti, Chief Executive Officer, and Edward Prajzner, Chief Financial Officer, will participate in investor meetings and a fireside chat at the Sidoti Virtual Investor Conference on Wednesday, June 23, 2021 at 1:45 PM Eastern Time. A live webcast of the presentation may be accessed via the Company’s website at www.mistrasgroup.com or at https://sidoti.cventevents.com/c/calendar/5be7c6b9-8c4d-4a45-bb2e-f585a0ba031d. One-on-one meetings will be scheduled on June 23rd and 24th. Investors interested in meeting with management should contact their Sidoti & Company representative. About...

CARLSBAD, Calif., June 21, 2021 (GLOBE NEWSWIRE) — Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that Marie Meynadier, Ph.D., founder of EOS imaging, has been appointed as an independent director to the ATEC Board. With over 25 years of experience in the high tech and medical device industries, Dr. Meynadier currently sits on boards of multiple medical technology companies in Europe and North America. She founded and served as Chief Executive Officer of EOS imaging until 2018, after which she remains a director and head of the Strategic Committee. Prior to her tenure at EOS, Dr. Meynadier served as Chief Executive Officer of Biospace Lab, a French preclinical imaging company, which she rapidly guided to profitability. She began...

HUNTSVILLE, Ala., June 21, 2021 (GLOBE NEWSWIRE) — Aerojet Rocketdyne has successfully tested a full-scale advanced solid rocket motor as part of an ongoing test series in support of Phase 2 of the Operational Fires (OpFires) program, a U.S. Defense Advanced Research Projects Agency (DARPA) effort to develop a ground-launched tactical hypersonic weapon. “This successful test demonstrates Aerojet Rocketdyne’s advanced technological capabilities to ensure our warfighters maintain the advantage,” said Eileen P. Drake, Aerojet Rocketdyne CEO and president. During the static test last month at Redstone Arsenal in Huntsville, the company demonstrated the variable-range technology that will enable OpFires to provide the military with intermediate-range missile capability. The solid rocket motor performed as expected through the duration...

REDMOND, Wash., June 21, 2021 (GLOBE NEWSWIRE) — MicroVision, Inc. (NASDAQ: MVIS), a leader in MEMS based solid state automotive lidar and micro-display technology for augmented reality, today announced it entered into a $140 million At-the-Market (ATM) equity offering agreement with Craig-Hallum Capital Group (Craig-Hallum). Under the agreement MicroVision may, from time to time, at its discretion offer and sell shares of its common stock having an aggregate value of up to $140 million through Craig-Hallum. MicroVision intends to use the net proceeds from the ATM, if any, for general corporate purposes, which may include, but are not limited to, working capital and capital expenditures as MicroVision continues to pursue its strategy to enhance shareholder value. “I am proud of the progress our Company has made advancing our automotive...

DURHAM, N.C., June 21, 2021 (GLOBE NEWSWIRE) — Novan, Inc. (the “Company” or “Novan”) (NASDAQ:NOVN) today announced the closing of the Company’s previously announced underwritten public offering (the “Offering”) of 3,636,364 shares of common stock at a public offering price of $11.00 per share. All of the shares of common stock sold in the offering were offered by the Company. In addition, the Company granted the underwriter of the Offering a 30-day option to purchase up to an additional 545,454 shares of its common stock. The gross proceeds from the offering were approximately $40 million, before deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company. Cantor Fitzgerald & Co. acted as the sole book-running manager for the Offering. In addition,...

PRINCETON, N.J., June 21, 2021 (GLOBE NEWSWIRE) — Oyster Point Pharma, Inc. (Nasdaq: OYST), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies to treat ophthalmic diseases, today announced that the Company will participate virtually in the LifeSci Partners Genetic Medicines Summit on Tuesday, June 22, 2021, at 2:00 p.m. ET. To access the live webcast, please visit the “Investors and News” section of the Oyster Point Pharma website at https://investors.oysterpointrx.com/. About Oyster Point PharmaOyster Point Pharma is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies to treat ophthalmic diseases. Investor Contact: Tim McCarthy LifeSci Advisors, LLC (212) 915-2564 investors@oysterpointrx.com Media...

WATERTOWN, Mass., June 21, 2021 (GLOBE NEWSWIRE) — C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company pioneering a new class of small-molecule medicines that selectively destroy disease-causing proteins through degradation, today announced the closing of an underwritten public offering of 4,887,500 shares of its common stock, including the exercise in full by the underwriters of their option to purchase up to an additional 637,500 shares of common stock, at a public offering price of $37.00 per share. The aggregate gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, were approximately $180.8 million. All of the shares in the offering were offered by C4T. J.P. Morgan, Jefferies, Evercore ISI, BMO Capital Markets and UBS Investment Bank...